Group name
Total
T2
35 (49.3%)
T3a-3b
remark
Pathological T-stage
ISUP 1
1 (1.4%)
ISUP 2
27 (38.0%)
ISUP 3
24 (33.8%)
ISUP 4
5 (7.0%)
ISUP 5
14 (19.7%)
Pathology outcomes